A&G Pharmaceutical
UEI: SN6SWFABJXL1
• CAGE: 1T9L5
Overview
Awardee Type
Parent
Federal Capability Statement
Precision Antibody service rapidly develops customized, high-affinity monoclonal & polyclonal antibodies to your target antigen. We also offer both in vivo and in vitro monoclonal antibody production, from pilot scale to large-scale manufacturing.
Headquarters
Columbia, MD
United States
United States
Most Recent Award
March 25, 2025
Calculating
Federal contract and grant recipient
A&G PHARMACEUTICAL, INC.
dba A & G PHARMACEUTICAL INC
(UEI SN6SWFABJXL1, CAGE 1T9L5)
is headquartered in Columbia MD.
Its primary registered NAICS is 541714 Research and Development in Biotechnology (except Nanobiotechnology).
The corporation
was founded in June 2000 and
federally registered in
June 2001.
Federal Award Analysis
A&G Pharmaceutical federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
A&G PHARMACEUTICAL, INC.
DBA
A & G PHARMACEUTICAL INC
UEI
SN6SWFABJXL1
CAGE Code
1T9L5
SBA Certifications
None
Self Certifications
For Profit Organization, Manufacturer of Goods
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
June 6, 2000
Initial Registration
June 8, 2001
Last Registration
July 16, 2025
Registration Activation
Dec. 19, 2024
Registration Expiration
Dec. 17, 2025
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
Manufacturer of Goods
Manufacturer of Goods
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Reported NAICS
Reported PSC
Accepts Credit Cards
Yes